4019 related articles for article (PubMed ID: 36153787)
21. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
Riccò M
Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
[TBL] [Abstract][Full Text] [Related]
22. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; Engela-Volker JS; McElvenny D; Rhodes S; Stocking K; Fletcher T; Martin C; Noertjojo K; Sampson O; Verbeek JH; Jørgensen KJ; Bruschettini M
Cochrane Database Syst Rev; 2022 May; 5(5):CD015112. PubMed ID: 35514111
[TBL] [Abstract][Full Text] [Related]
23. Critical reflections on the currently leading definition of sustainable employability.
Fleuren BPI; de Grip A; Jansen NWH; Kant I; Zijlstra FRH
Scand J Work Environ Health; 2016 Jun; 42(6):557-560. PubMed ID: 27548816
[TBL] [Abstract][Full Text] [Related]
24. Reducing unemployment benefit duration to increase job finding rates: a systematic review.
Filges T; Jonassen AB; Jørgensen AK
Campbell Syst Rev; 2018; 14(1):1-194. PubMed ID: 37131392
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
27. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
28. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
29. Re: Madsen et al. "Unnecessary work tasks and mental health: a prospective analysis of Danish human service workers".
Durand-Moreau Q; Loddé B; Dewitte JD
Scand J Work Environ Health; 2015 Mar; 41(2):216-7. PubMed ID: 25501916
[TBL] [Abstract][Full Text] [Related]
30. Occupation and SARS-CoV-2 infection risk among 108 960 workers during the first pandemic wave in Germany.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Deckert A; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(6):446-456. PubMed ID: 35670286
[TBL] [Abstract][Full Text] [Related]
31. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
32. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
33. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
[TBL] [Abstract][Full Text] [Related]
34. Letter to the Editor: EDUCATIONAL ACTIVITIES RELATED TO THE ICD-11 CHAPTER ON MENTAL DISORDERS.
Giallonardo V
Turk Psikiyatri Derg; 2021; 32(4):291-292. PubMed ID: 34964105
[TBL] [Abstract][Full Text] [Related]
35. Response to Dr Stevens' letter ref. Visitisen et al: "Short-term effects of night shift work on breast cancer risk: a cohort study of payroll data".
Kolstad HA; Garde AH; Hansen ÅM; Frydenberg M; Christiansen P; Vistisen HT; Bonde JP
Scand J Work Environ Health; 2017 Jan; 43(1):96. PubMed ID: 27935622
[TBL] [Abstract][Full Text] [Related]
36. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
37. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
[TBL] [Abstract][Full Text] [Related]
38. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
39. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
40. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
